Liver fat reduction may be the next major therapeutic target in MASH
boehringer-ingelheim.com/human-health/m…
boehringer-ingelheim.com/human-health/m…
Sak Chirapongsathorn, M.D.
@SakkarinC
Associate professor of Gastroenterology. Liver specialist | Research interests in MASLD and Cirrhosis | Living in Bangkok | Tweets are mine.
605 Following 400 Followers 734 Posts
Latest posts 5
Diarrhoeal burden in Thailand remains high, especially in children and older adults, with severe outcomes driven by Salmonella and C. difficile.
@TheLancet
@LancetGH
Full text:
authors.elsevier.com/sd/article/S27…
@TheLancet
@LancetGH
Full text:
authors.elsevier.com/sd/article/S27…
Prucalopride added to 2-L PEG improves bowel preparation quality and increases polyp detection compared with 2-L PEG alone.
@JGHofficial
doi.org/10.1111/jgh.70…
#JGH
#Colonoscopy
@JGHofficial
doi.org/10.1111/jgh.70…
#JGH
#Colonoscopy
A shorter duration of vasoactive therapy (as short as 24 hours) may be considered.
@BavenoCoop
#BavenoVIII
@BavenoCoop
#BavenoVIII
ACUTE VARICEAL BLEEDING
=> Shorter duration for vasoactive drugs after EBL
=> Potential benefit from pre-emptive TIPS even after 1-2 weeks from admission
=> Target PPH after TIPS: 8-13 mmHg => similar efficacy, less HE
#BavenoVIIIView quoted post on X
